This was a cultured human cell-line model, not an animal or human study, and cannot establish a clinical benefit, dose, or delivery method.What is the Texas Compassionate Use Program?It is Texas's medical cannabis program, established in 2015, providing regulated access to low-THC cannabis products for qualifying medical conditions.Are dialysis patients currently included in the Texas program?The policy analysis argues they should be explicitly included as a qualifying group, but describes this as a recommendation, not a change that has already occurred.What symptom burden do dialysis patients face, according to the paper?The analysis cites high rates of chronic pain, nausea, insomnia, depression, and opioid exposure among dialysis patients.Is the Texas paper based on new patient outcomes data?No
This only makes sense if you inject frequently or want to stock up long-term
GLP-1 RAs and dual or triple agonists incorporating GIP and/or glucagon receptor activity exhibit broad metabolic benefits, including improvements in steatosis, insulin sensitivity, inflammation, and body weight
Make sure to shake or rotate the vial gently until all of the powder has dissolved completely
As use of these drugs continues to expand, it becomes increasingly important to understand their real-world benefits and risks across populations. Since their introduction, GLP-1 RAs and SGLT2 inhibitors have seen a significant rise in popularity among people with Type 2 diabetes
Council on Pharmacy Standards (CPAP) , Electronic Prior Authorization (ePA) Standards (eLearning module) ( [31] ) ( [4] ) ( [38] ) ( [37] )